The Institutional Biosafety Committee (IBC) is responsible for reviewing all registrations for research, teaching, and training that involve the use of recombinant DNA by Georgia Tech faculty, staff or students and ensuring that the proposed activities comply with the federal “NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules” and all other applicable regulations. All scholarly activities involving recombinant DNA, regardless of source of funding, must be reviewed by the IBC. The Committee has the responsibility and authority to review, approve, disapprove, or require changes in research, teaching, and training activities involving recombinant DNA materials.
Georgia Tech’s Institutional Biosafety Committee is registered with the National Institutes of Health’s Office of Biotechnology Activities (OBA). IBC works closely with Georgia Tech’s Biosafety Officer in the Office of Environmental Health and Safety. Committee membership is structured in accordance with federal requirements. Members are appointed by the Executive Vice President for Research, who is also the Institutional Official for matters related to the Biosafety Committee. The IBC holds meetings as needed to review registrations.
This policy applies to all Georgia Tech Faculty, Staff, and Students.
To report suspected instances of noncompliance with this policy, please visit Georgia Tech’s EthicsPoint, a secure and confidential reporting system, at: https://secure.ethicspoint.com/domain/en/report_custom.asp?clientid=7508